BOLINGBROOK, Ill.– Ulta Beauty announced that Christopher DelOrefice has been named as Ulta Beauty’s next Chief Financial Officer. DelOrefice will begin his new role on December 5, 2025, and Chris Lialios will continue to serve as Interim Chief Financial Officer until such time.
DelOrefice is an experienced business leader who has led global, cross-functional teams at companies that have delivered superior financial performance. He joins Ulta Beauty from Becton Dickinson & Company, where he has served as Executive Vice President and Chief Financial Officer since September 2021.
Prior to Becton Dickinson, DelOrefice spent more than 20 years with Johnson & Johnson, a multinational pharmaceutical, biotechnology, and medical technologies company, and held financial leadership roles of increasing responsibility including as Vice President, Investor Relations, Vice President Finance and CFO, North America Hospital Medical Devices, and Vice President Finance and CFO, North America Consumer.
He serves on the Board of Directors for ResMed and serves as the Chair of ResMed’s audit committee.
“We are thrilled to welcome Chris to the Ulta Beauty family. Chris brings deep financial expertise and a proven track record of delivering leading financial performance and building high performing, engaged teams across global organizations,” said Kecia Steelman, president and chief executive officer. “With demonstrated experience leading core finance functions, global operations, strategy, corporate development, and enterprise transformation for public companies, Chris will be a great partner to our team as we continue to execute our Ulta Beauty Unleashed strategy and deliver long-term value for all our stakeholders.”
